Simplex Trading
ASLN

Simplex Trading’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Simplex Trading’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-220
Closed -$412 – 9925
2024
Q2 		$0 Buy
+220
New +$779 ﹤0.01% 10106
2024
Q1 		– Sell
-145
Closed -$727 – 10212
2023
Q4 		$0 Buy
145
+20
+16% +$151 ﹤0.01% 10121
2023
Q3 		$1K Sell
125
-156
-56% -$2.86K ﹤0.01% 8471
2023
Q2 		$8K Buy
281
+242
+621% +$7.49K ﹤0.01% 7640
2023
Q1 		$0 Sell
39
-65
-63% -$1.76K ﹤0.01% 10417
2022
Q4 		$1K Sell
104
-5
-5% -$96 ﹤0.01% 8989
2022
Q3 		$2K Buy
109
+100
+1,111% +$2.58K ﹤0.01% 9416
2022
Q2 		$0 Buy
+9
New +$200 ﹤0.01% 11396

Other funds holding ASLN

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Simplex Trading's ASLN Position: Q3 2024 in Review

Simplex Trading sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2024, closing a stake of 220 shares — an estimated $412 sold.

Simplex Trading first reported a position in ASLN in Q2 2022 and held it in 8 quarters. The position peaked at $8K in Q2 2023. 1 fund tracked by Wall St. Rank holds ASLN as of Q3 2024.

  • Simplex Trading reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 220 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2024, an estimated $412.
  • Simplex Trading first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q2 2022 and held it in 8 quarters.
  • Simplex Trading's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $8K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.